Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205T Li, P J Christos, J A Sparano, et al.
Seminars in Oncology|June 1, 1995
Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancerG W Sledge, N Robert, J A Sparano, et al.
Seminars in Oncology|October 1, 1994
Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experienceG W Sledge, N Robert, J A Sparano, et al.
Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 1997
Urinary estrogen metabolites and breast cancer: a case-control studyG C Kabat, C J Chang, J A Sparano, et al.
American Journal of Clinical Oncology|December 1, 1996
Phase II trial of prolonged continuous infusion of 5-fluorouracil and interferon-alpha in patients with advanced pancreatic cancer. Eastern Cooperative Oncology Group Protocol 3292J A Sparano, S Lipsitz, S Wadler, et al.
Cancer|October 1, 1991
Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alphaJ A Sparano, J P Dutcher, R Kaleya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Impact of anthracyclines in genomic high-risk, node-negative, HR-positive/HER2-negative breast cancerN Chen, J Q Freeman, S Yarlagadda, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2010
Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovaryE Chuang, N Wiener, P Christos, et al.
Leukemia & Lymphoma|July 1, 1994
Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimenJ A Sparano, P H Wiernik, M Strack, et al.
Pageof 6